We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+11.97%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$126B
AUM Growth
+$5.23B
(+4.3%)
Cap. Flow
-$4.63B
Cap. Flow
% of AUM
-3.67%
Top 10 Holdings %
Top 10 Hldgs %
31.85%
Holding
346
New
11
Increased
124
Reduced
177
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$421M |
| 2 |
Amazon
AMZN
|
+$401M |
| 3 |
ConocoPhillips
COP
|
+$282M |
| 4 |
Danaher
DHR
|
+$217M |
| 5 |
Flutter Entertainment
FLUT
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.04B |
| 2 |
Sony
SONY
|
+$581M |
| 3 |
Micron Technology
MU
|
+$543M |
| 4 |
Amgen
AMGN
|
+$498M |
| 5 |
Adobe
ADBE
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.56% |
| 2 | Healthcare | 25.76% |
| 3 | Industrials | 11.23% |
| 4 | Consumer Discretionary | 10.57% |
| 5 | Financials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Penumbra
PEN
$12.8B
| $7.04M | 0.01% |
27,420
-3,000
| -10% | -$817K |
|
277
Allogene Therapeutics
ALLO
$694M
| $6.46M | 0.01% |
5,719,140
+787,300
| +16% | +$1.05M |
|
|
GLXY
278
Galaxy Digital Inc
GLXY
$3.93B
| $6.37M | 0.01% |
+290,700
| New | +$5.9M |
|
279
LPL Financial
LPLA
$28.6B
| $6M | ﹤0.01% |
16,000
| – | – |
|
280
Gibraltar Industries
ROCK
$1.49B
| $5.64M | ﹤0.01% |
95,600
-6,700
| -7% | -$384K |
|
281
EPR Properties
EPR
$4.77B
| $5.53M | ﹤0.01% |
94,970
-11,930
| -11% | -$628K |
|
282
Array Technologies
ARRY
$855M
| $5.38M | ﹤0.01% |
911,600
| – | – |
|
283
Brinker International
EAT
$9.66B
| $5.09M | ﹤0.01% |
28,200
| – | – |
|
284
Valero Energy
VLO
$85.9B
| $4.91M | ﹤0.01% |
36,500
-17,890
| -33% | -$2.23M |
|
285
nLIGHT
LASR
$3.17B
| $4.84M | ﹤0.01% |
246,139
-7,040
| -3% | -$87.5K |
|
286
Savers
SVV
$1.88B
| $4.83M | ﹤0.01% |
473,525
| – | – |
|
|
FOLD
287
DELISTED
Amicus Therapeutics
FOLD
| $4.56M | ﹤0.01% |
796,100
-123,400
| -13% | -$796K |
|
288
Restaurant Brands International
QSR
$25.8B
| $4.52M | ﹤0.01% |
68,240
-30,000
| -31% | -$2M |
|
289
Ibotta
IBTA
$774M
| $4.39M | ﹤0.01% |
119,975
-4,700
| -4% | -$220K |
|
290
Merck
MRK
$318B
| $4.11M | ﹤0.01% |
51,900
-5,600
| -10% | -$445K |
|
|
LKFT
291
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.77B
| $4.01M | ﹤0.01% |
143,310
-3,900
| -3% | -$105K |
|
292
Rambus
RMBS
$11B
| $3.99M | ﹤0.01% |
62,300
-10,600
| -15% | -$568K |
|
293
Rivian
RIVN
$23.2B
| $3.74M | ﹤0.01% |
271,840
+7,900
| +3% | +$107K |
|
294
Dick's Sporting Goods
DKS
$18.7B
| $3.65M | ﹤0.01% |
+18,450
| New | +$3.42M |
|
295
SharkNinja
SN
$26.1B
| $3.52M | ﹤0.01% |
+35,600
| New | +$3.08M |
|
296
Guardant Health
GH
$22.6B
| $3.43M | ﹤0.01% |
65,990
+22,304
| +51% | +$996K |
|
297
Frontier Group Holdings
ULCC
$1.7B
| $3.1M | ﹤0.01% |
854,900
+420,600
| +97% | +$1.54M |
|
298
Stratasys
SSYS
$774M
| $3.05M | ﹤0.01% |
265,800
-611,355
| -70% | -$6.2M |
|
|
OS
299
DELISTED
OneStream Inc
OS
| $3M | ﹤0.01% |
105,900
-39,200
| -27% | -$976K |
|
|
LUCK
300
Lucky Strike Entertainment
LUCK
$911M
| $2.98M | ﹤0.01% |
326,900
| – | – |
|
Similar funds
VAM
Primecap Management's Q2 2025 Portfolio in Review
As of Q2 2025, Primecap Management held 346 positions worth $126B, up 4.3% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Primecap Management withdrew a net $4.63B in Q2 2025, closing 13 positions and reducing 177 holdings. Its most notable exit was Discover Financial Services, an estimated $98.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Capital One worth $116M.
- Primecap Management's largest Q2 2025 buy was Capital One: 545,321 shares worth $116M.
- Primecap Management added most to Charles Schwab in Q2 2025, an estimated $421M increase.
- Primecap Management's biggest Q2 2025 reduction was Eli Lilly, cutting an estimated $2.04B.
- Primecap Management fully exited Discover Financial Services in Q2 2025, selling an estimated $98.1M.
- Primecap Management's ten largest holdings make up 32% of its $126B portfolio in Q2 2025.
- Primecap Management opened 11 new positions and closed 13 in Q2 2025.
- Primecap Management's portfolio value rose 4.3% quarter-over-quarter to $126B.
Based on Primecap Management's 13F filing for Q2 2025, filed 11 Aug 2025.